Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/2
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
Apr 07, 2025Apr 08, 2025Foehr Matthew W
Pres
CEO
SellOmniab, Inc.OABI$2$38,764-0.51%
Feb 18, 2025Feb 20, 2025Foehr Matthew W
Pres
CEO
SellOmniab, Inc.OABI$3.67$123,033-0.88%
Jan 21, 2025Jan 22, 2025Foehr Matthew W
Pres
CEO
SellOmniab, Inc.OABI$3.24$135,468-1.10%
Dec 09, 2024Dec 10, 2024Foehr Matthew W
Pres
CEO
SellOmniab, Inc.OABI$4.13$56,308-0.37%
May 24, 2024May 28, 2024Foehr Matthew W
Pres
CEO
BuyOmniab, Inc.OABI$4.42$1M+6.35%
Mar 22, 2024Mar 25, 2024Foehr Matthew W
Pres
CEO
BuyOmniab, Inc.OABI$5.19$1M+7.18%
Dec 12, 2023Dec 13, 2023Foehr Matthew W
CEO
BuyOmniab, Inc.OABI$5.05$1M+7.03%
Nov 10, 2023Nov 13, 2023Foehr Matthew W
Pres
CEO
BuyOmniab, Inc.OABI$4.27$405,517+3.77%
Aug 14, 2023Aug 15, 2023Foehr Matthew W
Pres
CEO
BuyOmniab, Inc.OABI$5.48$246,600+1.89%
Jun 09, 2023Jun 12, 2023Foehr Matthew W
CEO
BuyOmniab, Inc.OABI$4.52$519,800+4.28%
May 12, 2023May 15, 2023Foehr Matthew W
CEO
BuyOmniab, Inc.OABI$3.4$1M+15.29%
Dec 12, 2022Dec 14, 2022Foehr Matthew W
Pres
CEO
BuyOmniab, Inc.OABI$3.77$564,765+7.54%
Nov 30, 2022Dec 01, 2022Foehr Matthew W
Pres
CEO
BuyOmniab, Inc.OABI$3.39$1M+14.96%
Nov 09, 2022Nov 10, 2022Foehr Matthew W
Pres
CEO
BuyOmniab, Inc.OABI$2.76$276,160+6.64%
May 13, 2022May 13, 2022Foehr Matthew W
Pres
COO
BuyLigand Pharmaceuticals IncLGND$82.76$206,910+1.42%
May 02, 2022May 03, 2022Foehr Matthew W
Dir
BuyViking Therapeutics, Inc.VKTX$2.47$111,195+28.80%
Nov 11, 2021Nov 12, 2021Foehr Matthew W
Pres
COO
SellLigand Pharmaceuticals IncLGND$163.02$2M-6.28%
Aug 04, 2021Aug 05, 2021Foehr Matthew W
Pres
COO
SellLigand Pharmaceuticals IncLGND$109.67$969,507-5.07%
Jun 10, 2021Jun 10, 2021Foehr Matthew W
Dir
BuyViking Therapeutics, Inc.VKTX$5.69$113,800+23.19%
Feb 04, 2021Feb 05, 2021Foehr Matthew W
Pres
COO
SellLigand Pharmaceuticals IncLGND$176.86$8M-20.94%
Aug 21, 2020Aug 25, 2020Foehr Matthew W
Pres
COO
SellLigand Pharmaceuticals IncLGND$112.86$824,190-4.49%
Jun 30, 2020Jun 30, 2020Foehr Matthew W
Dir
SellViking Therapeutics, Inc.VKTX$7.35$95,550-33.12%
Feb 27, 2020Feb 28, 2020Foehr Matthew W
Pres
COO
SellLigand Pharmaceuticals IncLGND$110$794,750-4.44%
Feb 14, 2020Feb 18, 2020Foehr Matthew W
Pres
COO
SellLigand Pharmaceuticals IncLGND$95.84$692,467-4.49%
Oct 01, 2018Oct 02, 2018Foehr Matthew W
Pres
COO
SellLigand Pharmaceuticals IncLGND$273.88$3M-10.22%
Aug 17, 2018Sep 19, 2018Foehr Matthew W
Dir
BuyRitter Pharmaceuticals IncRTTR$2.04$40,292+45.93%
Sep 04, 2018Sep 06, 2018Foehr Matthew W
Pres
COO
SellLigand Pharmaceuticals IncLGND$255.01$3M-10.41%
Aug 17, 2018Aug 20, 2018Foehr Matthew W
Dir
BuyRitter Pharmaceuticals IncRTTR$2.04$40,292+26.51%
May 10, 2018May 11, 2018Foehr Matthew W
Pres
COO
SellLigand Pharmaceuticals IncLGND$167.63$1M-7.99%
Feb 23, 2018Feb 27, 2018Foehr Matthew W
Pres
COO
SellLigand Pharmaceuticals IncLGND$152.98$832,824-5.38%